For: | Shrestha R, Giri S, Pathak R, Bhatt VR. Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia. World J Clin Oncol 2016; 7(4): 324-330 [PMID: 27579252 DOI: 10.5306/wjco.v7.i4.324] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v7/i4/324.htm |
Number | Citing Articles |
1 |
Parimi Ram Shashank, Intikabur Rahman. Essential Thrombocytosis. Assam Journal of Internal Medicine 2023; 13(1): 36 doi: 10.4103/ajoim.ajoim_25_22
|
2 |
Yan‑Bo Nie, Meng Sun, Colin He, Man‑Kai Ju, Fu‑Ling Zhou, San‑Yun Wu, Yi Zhou, Li Liu, Hui Shen, Ting‑Ting Huang, Pan Liu, Ying Xu, Liang Shao, Xue‑Lan Zuo. ASXL1 mutations in Chinese patients with essential thrombocythemia. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5939
|
3 |
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort. Haematologica 2019; 105(10): 2432 doi: 10.3324/haematol.2019.225839
|
4 |
Thamiris Silva Soares, João Sávio Silva Soares, Gabriela Lemes David. Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia. Hematology, Transfusion and Cell Therapy 2023; 45(1): 113 doi: 10.1016/j.htct.2021.08.011
|
5 |
Rajesh Shrestha, Smith Giri, James O Armitage, Vijaya Raj Bhatt. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study. Future Oncology 2017; 13(14): 1239 doi: 10.2217/fon-2016-0510
|
6 |
Mette Brabrand, Henrik Frederiksen. Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications. Cancers 2020; 12(10): 3061 doi: 10.3390/cancers12103061
|
7 |
Monia Marchetti, Alessandra Carobbio, Enrica Capitoni, Tiziano Barbui. Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review. American Journal of Hematology 2018; 93(5): 698 doi: 10.1002/ajh.25049
|
8 |
Yuhui Zhang, Yingdi Han, Guangshuai Teng, Chenxiao Du, Shan Gao, Weiping Yuan, Lei Zhang, Jie Bai. Incidence and risk factors for second malignancies among patients with myeloproliferative neoplasms. Cancer Medicine 2023; 12(8): 9236 doi: 10.1002/cam4.5666
|
9 |
Utsav Joshi, Adheesh Bhattarai, Suman Gaire, Simrat Gill, Vishakha Agrawal, Sumeet Kumar Yadav, Soon Khai Low, Prajwal Dhakal, Vijaya Raj Bhatt, Peter A. Kouides. Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study. Leukemia & Lymphoma 2022; 63(14): 3456 doi: 10.1080/10428194.2022.2123227
|